Reply to: Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer in patients with pre-treatment node-positive: Recommendation to optimize the performance
Publication date
2020-01
Authors
Simons, Janine M
Maaskant-Braat, A J G
Luiten, E J T
Leidenius, M H
van Nijnatten, T J A
Boelens, P G
Koppert, L B
van der Pol, Carmen C
van de Velde, C J H
Audisio, R A
Editors
Advisors
Supervisors
Document Type
Letter
Metadata
Show full item recordCollections
License
taverne
Abstract
Keywords
Axilla, Humans, Neoadjuvant Therapy, Sentinel Lymph Node Biopsy, Specialization, Surveys and Questionnaires, Axillary staging, Node-positive, Breast cancer, Treatment-response, Axillary lymph node dissection, Neoadjuvant systemic therapy, Taverne, Oncology, Surgery, Comment, Letter
Citation
Simons, J M, Maaskant-Braat, A J G, Luiten, E J T, Leidenius, M H, van Nijnatten, T J A, Boelens, P G, Koppert, L B, van der Pol, C C, van de Velde, C J H, Audisio, R A & Smidt, M L 2020, 'Reply to : Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer in patients with pre-treatment node-positive: Recommendation to optimize the performance', European Journal of Surgical Oncology, vol. 46, no. 1, pp. 218-219. https://doi.org/10.1016/j.ejso.2019.10.022